scPharmaceuticals Inc.
NASDAQ: SCPH0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- John H. Tucker
- Employees
- 162
- Headquarters
- Burlington, United States
- IPO year
- 2017
- Market cap
- $302.2M
- Website
- https://www.scpharmaceuticals.com
Loading SCPH…
Loading profile data…Frequently asked questions about SCPH
What does scPharmaceuticals Inc. (SCPH) do?
scPharmaceuticals Inc. is a pharmaceutical firm dedicated to developing and commercializing a variety of medicinal products. Its primary investigational therapy, FUROSCIX, is a specialized formulation of furosemide delivered through an on-body infusor, intended for managing congestion in heart failure patients. The company's pipeline also encomp...
Where does SCPH trade?
scPharmaceuticals Inc. (SCPH) trades on the NASDAQ Global Select.
What sector is SCPH in?
scPharmaceuticals Inc. (SCPH) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of scPharmaceuticals Inc.?
John H. Tucker is the chief executive officer of scPharmaceuticals Inc. (SCPH).
Where is scPharmaceuticals Inc. headquartered?
scPharmaceuticals Inc. is headquartered in United States.
Does SCPH pay a dividend?
scPharmaceuticals Inc. (SCPH) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SCPH go public?
scPharmaceuticals Inc. (SCPH) completed its initial public offering in 2017.